SUMMARY OF BASIC LEASE INFORMATIONLease • March 6th, 2019 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
Compound License Agreement for APG1197Compound License Agreement • March 6th, 2019 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York
This Compound License Agreement (the “Agreement”) effective as of the 2nd day of January, 2019, (the “Effective Date”) is made by and between Ascentage Pharma Group Corp. Ltd., a Hong Kong corporation and its affiliates (collectively, “Ascentage”), with a business address at 11/F, AXA CENTRE, Gloucester Road, Wanchai, Hong Kong, and Unity Biotechnology, Inc., a Delaware corporation (“Unity”), with a business address at 3280 Bayshore Blvd, Suite 100, Brisbane, California 94005. Each of Ascentage and Unity shall be a “Party,” and both the “Parties.”
